BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 31004274)

  • 1. B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.
    Bruijnen S; Tsang-A-Sjoe M; Raterman H; Ramwadhdoebe T; Vugts D; van Dongen G; Huisman M; Hoekstra O; Tak PP; Voskuyl A; van der Laken C
    Arthritis Res Ther; 2016 Nov; 18(1):266. PubMed ID: 27863504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts.
    Behnam Azad B; Lisok A; Chatterjee S; Poirier JT; Pullambhatla M; Luker GD; Pomper MG; Nimmagadda S
    J Nucl Med; 2016 Jun; 57(6):981-8. PubMed ID: 26912435
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
    Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the fate of bacteria-derived site-specific immunomodulators by positron emission tomography.
    Kirby A; Suchý M; Duan D; Bazett M; Kalyan S; Shuhendler AJ
    Nucl Med Biol; 2024; 132-133():108908. PubMed ID: 38599145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Detection of
    González MI; González-Arjona M; Cussó L; Morcillo MÁ; Aguilera-Correa JJ; Esteban J; Kestler M; Calle D; Cerón C; Cortes-Canteli M; Muñoz P; Bouza E; Desco M; Salinas B
    Int J Biomed Imaging; 2024; 2024():3655327. PubMed ID: 38665417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Intrinsically Zirconium-89 Radiolabeled Self-Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies.
    Goel S; Chen F; Luan S; Valdovinos HF; Shi S; Graves SA; Ai F; Barnhart TE; Theuer CP; Cai W
    Adv Sci (Weinh); 2016 Nov; 3(11):1600122. PubMed ID: 27980987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an
    Madden PJ; Arif MS; Becker ME; McRaven MD; Carias AM; Lorenzo-Redondo R; Xiao S; Midkiff CC; Blair RV; Potter EL; Martin-Sancho L; Dodson A; Martinelli E; Todd JM; Villinger FJ; Chanda SK; Aye PP; Roy CJ; Roederer M; Lewis MG; Veazey RS; Hope TJ
    Front Immunol; 2021; 12():810047. PubMed ID: 35003140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ImmunoPET: Concept, Design, and Applications.
    Wei W; Rosenkrans ZT; Liu J; Huang G; Luo QY; Cai W
    Chem Rev; 2020 Apr; 120(8):3787-3851. PubMed ID: 32202104
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Heskamp S; Raavé R; Boerman O; Rijpkema M; Goncalves V; Denat F
    Bioconjug Chem; 2017 Sep; 28(9):2211-2223. PubMed ID: 28767228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte remodeling by Plasmodium falciparum gametocytes in the human host interplay.
    Tibúrcio M; Sauerwein R; Lavazec C; Alano P
    Trends Parasitol; 2015 Jun; 31(6):270-8. PubMed ID: 25824624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging of a Zirconium-89 Labeled Antibody Targeting Plasmodium falciparum-Infected Human Erythrocytes.
    Duvenhage J; Ebenhan T; Garny S; Hernández González I; Leyva Montaña R; Price R; Birkholtz LM; Zeevaart JR
    Mol Imaging Biol; 2020 Feb; 22(1):115-123. PubMed ID: 31004274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT Imaging of Human TNFα Using [
    Beckford-Vera DR; Gonzalez-Junca A; Janneck JS; Huynh TL; Blecha JE; Seo Y; Li X; VanBrocklin HF; Franc BL
    Mol Imaging Biol; 2020 Feb; 22(1):105-114. PubMed ID: 31065895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Development of CD38-Targeted [
    Ghai A; Maji D; Cho N; Chanswangphuwana C; Rettig M; Shen D; DiPersio J; Akers W; Dehdashti F; Achilefu S; Vij R; Shokeen M
    J Nucl Med; 2018 Feb; 59(2):216-222. PubMed ID: 29025987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of DFO and DFO* conjugated to trastuzumab-DM1 for complexing
    Cho H; Al-Saden N; Lam H; Möbus J; Reilly RM; Winnik MA
    Nucl Med Biol; 2020; 84-85():11-19. PubMed ID: 31931305
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.